The following blog article, titled, “40 Years After Moon Landing: Why Can’t We Cure Cancer?”and written by Christopher Wanjek, LiveScience’s Bad Medicine Columnist, makes reference to cancers in general, of which there are about 100 different types, as apposed to prostate cancer treatments per se.

More than once in recent posts I have questioned the money spent on cancer research in the US over past decades, some 200 billion dollars according to Christopher Wanjek, (a monumental leap on my own estimate of 113 billion) and I am pleased to bring you his well considered appraisal of the question.

Unfortunately, Christopher has not mentioned the principal cause for the very obvious lack of progress in cancer research during the past forty years. I’m talking about Big Pharma’s control of mainstream research funding in universities and other such entities where research is conducted.

Many times, whistle-blowing scientists have reported that very successful research results have been secreted away by the funding drug company, never to see the light of day. Allegations such as this invariably relate to research results that can not be patented, so have little commercial value to the drug company. The potential new drug’s value to the health of the community is of little or no consequence to them and therefor, totally disregarded.

Read the blog at: 200 Billion Dollars Spent Chasing Cancer

Today’s quote:

“You wouldn’t believe how many FDA officials or relatives or acquaintances of FDA officials come to see me as patients in Hanover. You wouldn’t believe this, or directors of the AMA, or ACA, or the presidents of orthodox cancer institutes. That’s the fact.”—Hans Nieper MD

This entry was posted on Wednesday, July 15th, 2009 at 8:42 pm and is filed under Informative Web-Sites. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.